HPQ
57
2
APA
35
3
JBHT
48
2
ORLY
52
5
DOW
47
3
KLAC
59
3
DGX
29
2
HBI
56
3
MMM
37
2
AME
50
3
PX
58
5
LOW
46
3
WHR
64
2
ITW
48
5
R
61
2
AIZ
66
3
QRVO
20
2
GIS
37
2
ADM
27
2
FTI
63
2
HPQ
57
2
APA
35
3
JBHT
48
2
ORLY
52
5
DOW
47
3
KLAC
59
3
DGX
29
2
HBI
56
3
MMM
37
2
AME
50
3
PX
58
5
LOW
46
3
WHR
64
2
ITW
48
5
R
61
2
AIZ
66
3
QRVO
20
2
GIS
37
2
ADM
27
2
FTI
63
2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
31

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$51.98
Seasonality Move:
5.96%

7 Day Trial

ALL ACCESS PASS

$ 7

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.4% based on the past 14 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $52.19. The Score for BIB is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23.4% based on the past 14 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
31
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
47.20

Prediction Charts

Market Cap:
0
Price in USD:
52.19
Volume:
8.6K
Beta:
1.82

Technical Analysis

SMA50:
59.53
SMA100:
61.86
SMA200:
59.75
52-Wk Change:
-5.2%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 52.19 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-4 57.81 58.44 58.85 57.81
Dec-5 58.15 58.04 58.61 57.58
Dec-6 59.10 59.22 59.58 58.91
Dec-9 59.23 59.03 60.10 58.81
Dec-10 59.02 58.17 59.03 58.02
Dec-11 57.61 57.74 58.07 57.61
Dec-12 56.96 55.39 57.14 55.40
Dec-13 54.93 54.54 54.93 54.00
Dec-16 54.14 55.40 56.19 54.14
Dec-17 55.60 55.78 56.15 55.43
Dec-18 55.52 51.28 55.67 50.96
Dec-19 50.38 50.50 51.05 49.50
Dec-20 49.49 51.41 52.41 49.49
Dec-24 51.51 52.19 52.19 51.51

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.